dual histone deacetylase inhibitor/androgen receptor inhibitor (Texas A&M University system/Georgia Institute of Technology)

N/A

Report date: 2025/01/26 17:11:14
NME

Base Information

Drug Namedual histone deacetylase inhibitor/androgen receptor inhibitor (Texas A&M University system/Georgia Institute of Technology)
Drug Alias Namedual HDAC and AR/AR-V7 inhibitor (Texas A&M University system/Georgia Institute of Technology)SBI-46
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor degradersHistone deacetylase inhibitors
TargetsAndrogen ReceptorHistone deacetylase
Therapy Area/IndicationsHormone-Resistant Prostate Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTexas A&M University System
China Registration ClassN/A

Develop Information

Active CompaniesTexas A&M University SystemGeorgia Institute Of Technology
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A